Brief: Photocure Q2 EBITDA Loss At NOK 2.0 Mln
29/07/2026 07:04
BRIEF-Photocure Q2 EBITDA Loss At NOK 2.0 Mln July 29 (Reuters) - Photocure ASA PHO.OL:
HEXVIX/CYSVIEW REVENUES OF NOK 140.0 MILLION IN Q2
FOR 2026, PHOTOCURE NOW EXPECTS PRODUCT REVENUE GROWTH IN RANGE OF 8% TO 11% ON A CONSTANT CURRENCY BASIS
Q2 ADJUSTED EBITDA OF NOK 27.2 MILLION
TOTAL REVENUES ENDED AT NOK 142.5 MILLION IN Q2
Q2 EBIT ENDED AT NOK -9.4 MILLION
Q2 EBITDA WAS NOK -2.0 MILLION
Source text: ID:nObikGHVfa
Further company coverage: PHO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Photocure ASA
See all newsBrief: Photocure Q3 Adjusted EBITDA At NOK 18.5 Million
Brief: Photocure ASA Says New CFO Appointed
Brief: Photocure Says Welcomes FDA Proposal To Initiate Reclassification Of Blue Light Cystoscopy Systems From Class Iii To Class Ii
Brief: Photocure To Pursue Full Payment By Asieris
Brief: Photocure Q2 EBITDA Loss At NOK 2.0 Mln